Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men: Results From the 18-Year Follow-Up of a Large Cohort From Southern Germany
- 3 October 2006
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 48 (7) , 1369-1377
- https://doi.org/10.1016/j.jacc.2006.06.053
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markersEuropean Heart Journal, 2005
- Adipokines: molecular links between obesity and atheroslcerosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Adiponectin and the Development of Type 2 DiabetesDiabetes, 2004
- Plasma Adiponectin Levels and Risk of Myocardial Infarction in MenJAMA, 2004
- The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarctionHeart, 2003
- High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000Diabetologia, 2003
- Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiographyAmerican Heart Journal, 2003
- Association of Hypoadiponectinemia With Coronary Artery Disease in MenArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Adiponectin and protection against type 2 diabetes mellitusThe Lancet, 2003
- Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart DiseaseCirculation, 2000